While piloting Perrigo Co., Mr. Papa took steps akin to those that put Valeant on the hot seat. But Wall Street is questioning whether the man hired to effect change can succeed after drawing from a playbook similar to Valeant’s at his previous company. He raised prices of prescription drugs—by more than many rivals did—including boosting lice treatment permethrin and a steroid... Upon taking the helm of Valeant Pharmaceuticals International Inc., Joseph Papa promised to start a “new chapter” at the struggling company.

Source: Wall Street Journal July 05, 2016 19:07 UTC